Can a weight-loss injection truly safeguard your vision? :eyes:<br /><br />A significant study conducted in the US involving more than 170,000 patients indicates that Mounjaro, or tirzepatide, might greatly reduce the likelihood of developing diabetic retinopathy — a severe eye ailment that can result in blindness.<br /><br />With over 25% of individuals with diabetes experiencing retinal damage, this discovery could transform lives. This is particularly important in light of recent alerts connecting other weight-loss medications such as semaglutide, found in Wegovy and Ozempic, to rare instances of vision impairment.<br /><br />Could this represent the future of diabetes management? Tune in now to learn how this injection might help shield millions from losing their sight.
